miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

(2014) Allen S. Ho et al.   Translational Oncology

Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma

(2012) Vladimir A. Valera et al.   Journal of Cancer

Overexpression of miR-210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells

(2011) Chisato Nakada et al.   JOURNAL OF PATHOLOGY

miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation

(2011) Nicole M.A. White et al.   JOURNAL OF UROLOGY

The VHL-dependent regulation of microRNAs in renal cancer

(2010) Calida S Neal et al.   BMC Medicine

MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)

(2010) Soken Tsuchiya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Accurate Molecular Classification of Renal Tumors Using MicroRNA Expression

(2010) Eddie Fridman et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression

(2010) Z Chen et al.   ONCOGENE

MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU

(2010) Elena Favaro et al.   PLoS One

Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds

(2010) S. Biswas et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Differentiation impairs low pH-induced Ca2+ signaling and ERK phosphorylation in granule precursor tumour cells

(2009) Wan-Chen Huang et al.   CELL CALCIUM

MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2

(2009) Stephen Y. Chan et al.   Cell Metabolism

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

(2009) A. C. Young et al.   CLINICAL CANCER RESEARCH

Identification of a MicroRNA Panel for Clear-cell Kidney Cancer

(2009) David Juan et al.   UROLOGY

HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma

(2008) John D. Gordan et al.   CANCER CELL

hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer

(2008) C. Camps et al.   CLINICAL CANCER RESEARCH

Hypoxia induces microRNA miR-210 in vitro and in vivo

(2008) Kati Pulkkinen et al.   FEBS LETTERS

Iron–sulfur cluster biogenesis and human disease

(2008) Tracey A. Rouault et al.   TRENDS IN GENETICS